FY2025 · ended Dec 31, 2025 · Revenue $300.79M, -10.0% YoY · Filed Mar 12, 2026
SkinHealth Systems Inc. (SKIN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $300.8 million and a net loss of $9.5 million. Free cash flow was $37.2 million. As of Sep 30, 2026 it held $112.4 million in cash and investments and $21.3 million in total debt.
Revenue (TTM)
$288.56M
-4.4% vs year-ago TTM
Net income (TTM)
$-18.29M
-55.7% vs year-ago TTM
Operating cash flow (TTM)
$23.58M
-39.2% vs year-ago TTM
Free cash flow (TTM)
$22.69M
-41.1% vs year-ago TTM
EPS (TTM)
$-0.13
+52.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
127.77M
+2.0% vs prior year
Net cash
$91.11M
as of Sep 30, 2026
Operating margin
2.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SKIN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Long Beach, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1818093
- Former names
- Beauty Health Co (until Apr 20, 2026); Vesper Healthcare Acquisition Corp. (until Apr 30, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M |
| Operating income | -$20.8M | -$67.8M | -$130.9M | -$25.8M | -$39.9M |
| Net income | -$9.5M | -$29.1M | -$100.1M | $44.2M | -$378.8M |
| Diluted EPS | -$0.16 | -$0.36 | -$0.76 | -$0.23 | -$3.71 |
| Operating cash flow | $37.5M | $16.1M | $21.8M | -$106.6M | -$28.4M |
| Free cash flow | $37.2M | $15.4M | $17.9M | -$117.4M | -$39.6M |
| Total assets | $499.8M | $685.7M | $929.1M | $1.0B | $1.2B |
| Total liabilities | $438.7M | $633.9M | $869.7M | $836.0M | $916.5M |
| Stockholders' equity | $61.1M | $51.8M | $59.4M | $167.1M | $298.0M |
| Cash and investments | $232.7M | $370.1M | $523.0M | $568.2M | $901.9M |
| Total debt | $14.4M | $16.0M | $13.9M | $17.6M | $16.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
All 438 SkinHealth Systems Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.